m+Medelevator.RU
← Поиск публикаций
International journal of hematology-oncology and stem cell research · 2017

Protective Isolation for Patients with Haematological Malignancies: A Pilot Study Investigating Patients' Distress and Use of Time.

Название и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Annibali O, Pensieri C, Tomarchio V, Biagioli V, Pennacchini M, Tendas A, Tambone V, Tirindelli MC

Аннотация

Background: Patients with haematological malignancies are often hospitalized in protective isolation until full neutrophil recovery in order to prevent infections. This descriptive pilot study evaluate the level of isolation-related distress and the use of free time in a sample of Italian onco-haematological patients who were hospitalized in protective isolation. Materials and Methods: Participants were 18 patients hospitalized in hematologic ward to receive induction therapy (n=12) or autologous stem cell transplant (n=6). They completed a self-report questionnaire before discharge. Results: Participants reported a moderate level of isolation-related distress, anxiety, and boredom: the more the anxiety and the boredom, the more the distress (r=.77; PConclusion: Haematology Units should support isolated patients in spending their time in recreational activities, allowing more contacts with immediate relatives and friends, providing free TV and Wi-Fi connection inside the room. In addition, patients should have to keep themselves physically active. Isolation-related distress could also be reduced by providing psychological support.

Перевод полного текста: Перевод в очереди

Читать найденный полный текст

https://creativecommons.org/licenses/by/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, ( http://creativecommons.org/licenses/by/3.0/ ) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Introduction

Patients with haematological malignancies, especially those who undergo haematopoietic stem cell transplantation (HSCT), are often hospitalized in protective isolation until full neutrophil recovery in order to prevent infections 1 - 2 . Protective isolation measures are not supported by definitive scientific evidence and every single center acts in different ways. In Italy, protective strict isolation is commonly used for patients receiving high-dose chemotherapy or for those receiving autologous HSCT. Usually, the patient is alone in a germ-free room during the entire hospitalization period, he has to follow preventive self-care behaviors and he cannot receive visits except in accordance with ward policy.

During isolation, patients have to deal not only with treatment-related complications and adverse events such as physical symptoms and changes in body image but also with isolation-related psychological distress, including loss of control and lack of contact with family members. Although, some patients are able to adapt themselves to this new condition, usually being alone in a hospital room for a certain period of time could become a devastating experience. In some cases, patients can suffer from loneliness, depression, anxiety, confusion, feelings of esclusion, which in some case could lead to violence, escape behavior or suicidal ideation. As a consequence, it is necessary to investigate deeply the level of isolation-related distress and the associated variables. In particular, patients who spend their time in recreational activities, such as the use of technology, may better cope with isolation experience.

The aim of this study was to evaluate the level of isolation-related distress and to analyze the way in which isolated patients spend their time during the admission into hospital.

MATERIALS AND METHODS

Design

From August 2010 to May 2012, we conducted a descriptive prospective pilot study aimed to evaluate the level of isolation-related distress and the use of free time during the admission into hospital in a cohort of patients with haematological malignancies hospitalized in the Haematology ward at Campus Bio-Medico University Hospital in Rome. The study was approved by the Ethics Committee of Campus Bio-Medico University.

Setting

The hematology ward where the study was conducted included 4 HEPA-filtered single rooms with en suited toilet where patients remained until discharge 3 - 9 . Patients could not leave the room, unless required, for example in case of medical procedures (e.g. radiologic) or emergencies. The policy for visitors allowed only one family member/friend visits twice a day for two-hours in the morning (12 p.m.–2 p.m.) and in the afternoon (6–8 p.m.). Dietary restrictions and rigorous preventive measures, such as shower and mouth care, were mandatory.

Participants and data collection

Participants were patients affected by haematologic malignancies who were hospitalized in protective isolation in order to receive chemotherapy followed or not by autologous HSCT. Patients were invited to participate in the study by the clinical staff of the Unit. After having signed an informed consent, participants were asked to complete a self-report questionnaire at the end of their hospitalization. The questionnaire included data about socio-demographic characteristics, relational network and visitors, use of time during hospitalization and use of technology. In addition, their level of isolation-related distress, like discomfort, lack of happiness, boredom, lack of serenity, anxiety, and anger was measured with 6 items on a 5-point Likert scale; higher scores indicated higher isolation-related distress. Boredom and anxiety were also assessed with single items ranging from 0 to 10.

Descriptive statistics were analyzed for each variables studied. The levels of distress, anxiety, and boredom were analyzed in relation to the use of time through univariate analysis of variance (ANOVA).

Results

Eighteen patients were enrolled in this study, 12/18 received standard dose chemotherapy, followed in n=6/18 by autologous HSCT. Table 1 shows the socio-demographic and clinical characteristics of the sample. Median age was 55 years (21- 72). 9/18 patients were male (50%) and 9/18 were female (50%). The duration of hospitalization varied from 17 to 122 days. Participants reported to have from 2 to 9 close relatives. The majority of patients (n=13/18; 72.2%) received visits from relatives every day during their hospital period, while 4/18 (22.2%) patients received 2-3 visits per week, and 1/18 (5.6%) patient received only one visit per week. Only 6/18 (33%) reported visits from friends or not closed relatives.

Table 1
Demographic and clinical characteristics of the 18 participants

CharacteristicN%
Age Median (range)55 (21-72)-
Sex
Male950.0
Female950.0
Marital status
Single316.7
Married1372.2
Divorced15.6
Widow15.6
Educational level
Primary school15.6
Secondary school950.0
High school738.9
University15.6
Work status
Employed633.3
Unemployed1266.7
Diagnosis
Acute leukemia1055.6
Non-Hodgkin Lymphoma527.8
Multiple Myeloma316.7
Status of the disease
Newly diagnosed422.2
Partial response211.1
Relapsed422.2
Complete remission844.4
Number of previous admissions
1st admission950.0
2nd or more admission950.0
Days of hospitalization Median (range)49 (17-122)-

Participants reported a mean level of isolation-related distress of 2.94 (SD=1.02), indicating moderate distress. Their level of anxiety, as measured through a single item, was moderate as well (mean=5.22; SD=3.67). Their level of boredom, as measured through a single item, was also moderate (mean=5.94; SD=3.24). These variables were positively associated with each other: the more the anxiety and the boredom, the more the distress (r=.77; P<.001), (r=.79; P<.001), respectively.

In terms of frequency of each isolation-related feeling ( Table 2 ), the majority of patients reported never (38.9%) or rarely (22.2%) discomfort. The most experienced feeling was boredom (61.1%) and several patients complained of being always (11.1%) or often (50%) bored. Most of the patients reported to be rarely (33.3%) or never (44.4%) happy, but nearly half of the sample (44.4%) felt often (33.3%) or always (11.1%) calm. Only few patients experienced anger (27.8%); the majority of them (67.7%) rarely (16.7%) or never (50%) got angry. While 8/18 (44.5%) patients were always (16.7%) or often (27.8%) anxious, 10/18 (55.5%) experienced anxiety rarely (22.2%) or never (33.3%).

Table 2
Frequencies and percentages of feelings reported during isolation
Note: in bold the highest frequency for each feeling

Always n (%)Often n (%)Sometimes n (%)Rarely n (%)Never n (%)
Discomfort1 (5.6)6 (33.3)-4 (22.2)7 (38.9)
Boredom2 (11.1)9 (50.0)-3 (16.7)4 (22.2)
Anxiety3 (16.7)5 (27.8)-4 (22.2)6 (33.3)
Anger4 (22.2)1 (5.6)1 (5.6)3 (16.7)9 (50.0)
Happiness1 (5.6)1 (5.6)2 (11.1)6 (33.3)8 (44.4)
Serenity2 (11.1)6 (33.3)2 (11.1)6 (33.3)2 (11.1)

Regarding the perception and use of time during isolation, only few patients reported that they spent their time in sleeping (n=2/18; 11.1%) or resting (n=3/18; 16.7%). Many patients answered they had something to do (n=7/18; 38.9%). Unfortunately, half of the sample (n=9/18; 50%) reported pessimistic thinking about their future and their health. On the other hand, many patients (n=11/18; 61.1%) reported that they spent their time thinking about their lives and their future goals during isolation. Besides, many patients (n=10; 55.6%) reported the desire of staying with other people.

Participants who reported pessimistic thinking had higher isolation-related distress (P=.004), as well as anxiety (P<.001) and boredom (P=.001). In addition, patients who had something to do during isolation felt less anxiety than those who had nothing to do (P=.006).

Since many patients (n=11/18; 61.1%) used Internet in their daily life for checking emails, surfing social networking sites or reading e-books, nearly half of the sample (n=8; 44.4%) expressed a desire to have the Wi-Fi connection inside their hospital rooms. Although most of the patients practiced at least a sport in their daily life (n=12/18; 66.7%), they spent their time in sedentary activities during the hospitalization period. The most frequent activities included: watching TV (n=13/18; 72.2%), reading (n=10/18; 55.6%), thinking (n=6/18; 33.3%), surfing the Internet or using the PC (n=6; 33.3%), and playing games or making cross-words (n=3/18; 16.7%).

Most of the participants believed to have been on isolation for a lot (n=9/18; 50%) or too much time (n=4/18; 22.2%), while only few of them believed to have spent enough (n=3/18; 16.7%) or short (n=2/18; 11.1%) time in isolation.

Discussion

This prospective descriptive pilot study assessed the level of isolation-related distress and the use of time during hospitalization in 18 patients with haematologic malignancies hospitalized in a University Hospital in Italy. Isolation’s duration was comparable with other haematology centers in Italy, and was perceived as long/too long by most of the sample. This could suggest the need of an early discharge after high-dose chemotherapy and the possibility to complete the medical care at home.

About the use of time during isolation, findings emphasized the importance of having a TV and a free Wi-Fi connection inside the room; as a consequence, all haematology centers should provide isolation rooms with these services. However, even when patients can spend their time watching TV, reading, thinking and surfing Internet or using the PC, they might experience boredom. In addition, the majority of patients experienced boredom as well as anxiety, and suffered from isolation-related distress. Boredom, defined as the dissatisfaction associated with the perception of time as passing slowly, has been described as an attribute of environmental loneliness .This underlines the importance for isolated patients to manage their time alone in order to avoid experiencing boredom, which can make them feel lonelier 11 - 27 .

Moreover, participants reported their desire of staying with other people, which can result as a crucial aspect to fight against boredom and anxiety. Spending more time with family members/friends might improve patients’ quality of life during isolation. For example, haematology centers could prolong visiting hours, install an intercom, or create common protective spaces for family meeting. Other efforts to reduce isolation discomfort could include the use of Tablet to enhance internet’s relationship with family members, friends and patients’ communities or to invest free time in games, films, musics and also the creation of virtual world like 3D immersive games or 3D simulated environment in which participants could live in virtual reality. Recently, some medical fields like rehabilitation medicine have used this type of technological support with success 28 . It is important to improve patient’s physical status and at the same time to support psychological aspect that would influence the patient’s well-being such as emotional distress and lack of social support 29 .

In addition, since many patients have already incorporated an exercise program into their daily life, and during isolation they may experience loss of muscles and weight due to physical complications, they should have to keep themselves physically active to help maintain muscle strength and a healthy weight 30 - 31 . Meanwhile, we could improve the physical activity of patients through the help of technology: patients could use workout and fitness games on video game consoles via Tablets or Smartphones to improve motion. These forms of technology have been successful in providing an opportunity for patients to deal with isolation and boredom and also in improvement of outcome following stroke rehabilitation 32 , 33 .

Patients might also benefit from psychological support as half of the participants with increased isolation-related distress engaged in pessimistic thinking about their future and their health.

CONCLUSION

In conclusion, it is essential to ensure that the best treatment will be given to a patient, but there is “ no profit in curing the body if in the process you destroy the soul ” (Samuel H. Golter), so every single Hematology Unit in Hospitals should support isolated patients by allowing them to spend more time with relatives and friends. Scientific data demonstrated that personal contact is one of the best forces to cope with distress and isolation. Each ward should provide patients with recreational opportunities, including free TV and Wi-Fi connection inside the room. Furthermore, patients should keep themselves physically active. Isolation-related distress could also be reduced by providing psychological support.

References

1 Saria M Preventing and managing infections in neutropenic stem cell transplantation recipients: evidence-based review Clin J Oncol Nurs 2011 15 2 133 9 21444280 10.1188/11.CJON.133-139

2 Yokoe D Casper C Dubberke E Infection prevention and control in health-care facilities in which hematopoietic cell transplant recipients are treated Bone Marrow Transplant 2009 44 8 495 507 19861984 10.1038/bmt.2009.261

3 Vokurka S Bystrická E Svoboda T The availability of HEPA-filtered rooms and the incidence of pneumonia in patients after haematopoietic stem cell transplantation (HSCT): results from a prospective, multicentre, eastern European study J Clin Nurs 2014 23 11-12 1648 52 24354726 10.1111/jocn.12286

4 Mank A van der Lelie H Is there still an indication for nursing patients with prolonged neutropenia in protective isolation? An evidence-based nursing and medical study of 4 years experience for nursing patients with neutropenia without isolation Eur J Oncol Nurs 2003 7 1 17 23 12849571 10.1054/ejon.2002.0216

5 Caselli D Cesaro S Livadiotti S Preventing transmission of infectious agents in the pediatric in-patients hematology-oncology setting: What is the role for non-pharmacological prophylaxis? Pediatr Rep 2011 3 1 e9 10.4081/pr.2011.e9 PMC3103128 21647282

6 Hayes-Lattin B Leis JF Maziarz RT Isolation in the allogeneic transplant environment: How protective is it? Bone Marrow Transplant 2005 36 5 373 81 15968294 10.1038/sj.bmt.1705040

7 Ariza-Heredia EJ Chemaly RF Infection control practices in patients with hematological malignancies and multidrug-resistant organisms: Special considerations and challenges Clin Lymphoma Myeloma Leuk 2014 14 Suppl S104 10 25486947 10.1016/j.clml.2014.06.021

8 Bevans M Tierney DK Bruch C Hematopoietic stem cell transplantation nursing: a practice variation study Oncol Nurs Forum 2009 36 6 E317 25 19887345 10.1188/09.ONF.E317-E325 PMC3459318

9 Hicheri Y Einsele H Martino R Environmental prevention of infection in stem cell transplant recipients: a survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation Transpl Infect Dis 2013 15 3 251 8 23465046 10.1111/tid.12064

10 Lee SJ Astigarraga CC Eapen M Variation in supportive care practices in hematopoietic cell transplantation Biology of Blood and Marrow Transplantation 2008 14 11 1231 38 18940677 10.1016/j.bbmt.2008.08.008 PMC3304538

11 Tecchio C Bonetto C Bertani M Predictors of anxiety and depression in hematopoietic stem cell transplant patients during protective isolation Psycho-Oncology 2013 22 8 1790 7 23132747 10.1002/pon.3215

12 Prieto JM Atala J Blanch J Patient-rated emotional and physical functioning among hematologic cancer patients during hospitalization for stem-cell transplantation Bone Marrow Transplant 2005 35 3 307 14 15580279 10.1038/sj.bmt.1704788

13 Vottero B Rittenmeyer L The hospitalised patients’ experience of being in protective/source isolation: a systematic review of qualitative evidence JBI Libr Syst Rev 2012 10 16 935 976 27820463 10.11124/01938924-201210160-00001

14 Biagioli V Piredda M Alvaro R The experiences of protective isolation in patients undergoing bone marrow or haematopoietic stem cell transplantation: systematic review and metasynthesis Eur J Cancer Care (Engl) 2017 26 5 10.1111/ecc.12461 26892767

15 Dunn E Arber A Gallagher A The immediacy of illness and existential crisis: patients' lived experience of under-going allogeneic stem cell transplantation for haematological malignancy. A phenomenological study Eur J Oncol Nurs 2016 21 90 6 26952683 10.1016/j.ejon.2016.01.001

16 Zamanzadeh V Valizadeh L Sayadi L Life in limbo: experiences of Iranian hematopoietic stem cell transplantation recipient patients and nurses in a qualitative study Int J Hematol Oncol Stem Cell Res 2013 7 3 25 33 24505532 PMC3913145

17 Biagioli V Piredda M Mauroni MR The lived experience of patients in protective isolation during their hospital stay for allogeneic haematopoietic stem cell transplantation Eur J Oncol Nurs 2016 24 79 86 27697280 10.1016/j.ejon.2016.09.001

18 Tichelli A Labopin M Rovó A Increase of suicide and accidental death after hematopoietic stem cell transplantation: A cohort study on behalf of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation (EBMT) Cancer 2013 119 11 2012 21 23512286 10.1002/cncr.27987 PMC3698695

19 Molassiotis A Further evaluation of a scale to sceen for risk of emotional difficulties in bone marrow transplant recipients J Adv Nurs 1999 29 4 922 7 10215984 10.1046/j.1365-2648.1999.00979.x

20 Faucher C Le Corroller Soriano AG Esterni B Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs Bone marrow transplant; 2012 47 4 549 55 21725375 10.1038/bmt.2011.126

21 Bergkvist K Larsen J Johansson UB Hospital care or home care after allogeneic hematopoietic stem cell transplantation – Patients' experiences of care and support Eur J Oncol Nurs 2013 17 4 389 95 23347992 10.1016/j.ejon.2012.12.004

22 Fernández-Avilés F Carreras E Urbano-Ispizua A Case-control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematologic malignancies J Clin Oncol 2006 24 30 4855 61 17001069 10.1200/JCO.2006.06.4238

23 Paul TM Liu SV Chong EA Outpatient autologous stem cell transplantation for patients with myeloma Clin Lymphoma Myeloma Leuk 2015 15 9 536 40 26141214 10.1016/j.clml.2015.05.006

24 Mank AP Schoonenberg C Bleeker K Early discharge after high dose chemotherapy is safe and feasible: a prospective evaluation of 6 years of home care Leuk Lymphoma 2015 56 7 2098 104 25330445 10.3109/10428194.2014.974039

25 Schulmeister L Quiett K Mayer K Quality of life, quality of care, and patient satisfaction: perceptions of patients undergoing outpatient autologous stem cell transplantation Oncol Nurs Forum 2005 32 1 57 67 15660144 10.1188/05.ONF.57-67

26 Svendsen L.F.H A philosophy of boredom 2005 6th edn. London, UK Reaktion Books

27 Karhe L Kaunonen M Patient experiences of loneliness: An evolutionary concept analysis ANS Adv Nurs Sci 2015 38 4 E21 34 26517346 10.1097/ANS.0000000000000096

28 Ustinova KI Leonard WA Cassavaugh ND Development of a 3D immersive videogame to improve arm-postural coordination in patients with TBI J Neuroeng Rehabil 2011 8 61 22040301 10.1186/1743-0003-8-61 PMC3214849

29 Sasaki T Akaho R Sakamaki H Mental disturbances during isolation in bone marrow transplant patients with leukemia Bone Marrow Transplant 2000 25 3 315 8 10673704 10.1038/sj.bmt.1702117

30 Beattie S Lebel S Tay J The influence of social support on hematopoietic stem cell transplantation survival: a systematic review of literature PLoS One 2013 8 4 e61586 23637862 10.1371/journal.pone.0061586 PMC3630123

31 Bergenthal N Will A Streckmann F Aerobic physical exercise for adult patients with haematological malignancies Cochrane Database Syst Rev 2014 11 CD009075 25386666 10.1002/14651858.CD009075.pub2

32 Van Haren IE Timmerman H Potting CM Physical exercise for patients undergoing hematopoietic stem cell transplantation: systematic review and meta-analyses of randomized controlled trials Phys Ther 2013 93 4 514 28 23224217 10.2522/ptj.20120181

33 Saposnik G Mamdani M Bayley M Effectiveness of virtual reality using Wii gaming technology in stroke rehabilitation Int J Stroke 2010 5 1 47 51 20088994 10.1111/j.1747-4949.2009.00404.x PMC4880012

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты